J. Melville ("Mel") Engle
Mr. Engle is President, CEO of Engle Strategic Solutions where his practice specializes in consulting and coaching for CEOs and Business Owners.
With over 20 years leading both large and small-sized firms as CEO, Mr. Engle has extensive experience in turning companies around, driving sales, creating business, raising money, and developing high performance teams. A global Life Science senior executive with a clear and recognizable track record of relevant professional successes within the Pharmaceutical, Biotech and Medical Device industries, Mr. Engle has served in multiple top level capacities; e.g. President, CEO, Director, Chairman of the Board, CFO, Regional Director (North America), Managing Director (Canada) and Senior VP of Sales (US). He has launched hundreds of products, lived/worked domestically and internationally, managed both regional and worldwide operations, successfully sold two firms and bought three others.
Prior to starting his consulting practice in 2012, Mr. Engle was CEO, Chief Executive Officer of Thermogenesis (NASDAQ: KOOL) and later became the firm's Chairman of the Board. Thermogenesis designs, develops and sells Medical Devices that enable the practice of regenerative medicine, including those used in the collection, processing and cryopreservation of adult stem cells and other cellular tissues.
In 2002, Mr. Engle was recruited by Merck KGaA (XETRA: MRK) to lead Dey L.P., as President and CEO. Dey L.P. was a pharmaceutical company focused on the development and commercialization of products for respiratory, allergy and other breathing disorders. Mr. Engle was instrumental in transforming Dey's company strategy from 90% commodity generics to 90% branded products, resulting in consecutive years of significant growth. During Mr. Engle's tenure, sales increased from $250 million to over $600 million. Dey L.P. was a cornerstone company within Merck Generics Group (MGG), a division of Merck KGaA (www.merckgroup.com). Mr. Engle was also Regional Director, North America for MGG, and led all of their North American businesses, specifically Dey L.P., Genpharm, Inc. (Canada) and Genpharm, L.P. (U.S.) with total sales of $800 million and 1,200 employees. Mr. Engle left Dey L.P. in late 2007 after Merck KGaA sold all the assets of MGG (including Dey L.P.) to Mylan Laboratories (NASDAQ: MYL) for nearly $7 billion.
Following his time at Dey L.P., Mr. Engle led VC-based Raydiance-Inc., an ultra-short pulse laser company, as the firm's CEO.
Earlier, Mr. Engle was CEO of two public Medical Device companies--Anika Therapeutics (NASDAQ: ANIK), located in Boston, MA, which specialized in the field of orthobiologic, ophthalmic and anti-adhesion products, and US Medical Products (BB: USMP), an Austin, TX-based generic orthopedic implant company.
From 1980 to 1994, Mr. Engle was a senior executive with Allergan, Inc. (NYSE: AGN). Allergan marketed branded eye care pharmaceuticals, surgical and diagnostic equipment, dermatological products and Botox. He played key roles within the organization as CFO, Managing Director, Canada (residing in Toronto), Senior Vice President, Latin America/Canada, and Senior Vice President, U.S. Sales.
Mr. Engle has led boards of both public and private for-profit companies. He was Lead Independent Director and Audit Committee Chair of Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) and Chairman of the Board of Anika Therapeutics, Inc. and Thermogenesis Corp. He also was a board member of Visicon Technologies (www.visicontech.com), a privately-held, automated visual inspection company. Mr. Engle is currently Chairman of the Board of WindGap Medical, Inc., (www.windgapmedical.com) and Member of the Board and Compensation Committee Chair of Precision Therapeutics (NASDAQ: AIPT)..
Mr. Engle received his MBA (Finance) from USC and BS (Accounting) from Colorado University. He has been an active member with many non-profits within the local community. The Napa Chamber of Commerce and State of California honored Mr. Engle as Napa’s “2007 Citizen of the Year” for his community leadership.
Engle Strategic Solutions